ABSTRACT Monoclonal antibodies were generated against the intermediate filament proteins of different human cells. The reactivity of these antibodies with the different classes of intermediate filament proteins was determined by indirect immunofluorescence on cultured cells, immunologic identification on SDS polyacrylamide gels ("western blot" experiments), and immunoperoxidase assays on intact tissues. The following four antibodies are described: (a) an antivimentin antibody generated against human fibroblast cytoskeleton; (b), (c) two antibodies that recognize a 54-kdalton protein in human hepatocellular carcinoma cells; and (d) an antikeratin antibody made to stratum corneum that recognizes proteins of molecular weight 66 kdaltons and 57 kdaltons.
kdaltons, present in skin and a wide range of epithelial cells (5) (6) (7) (8) . (c) Desmin, a 52-kdalton protein characteristic of cells of muscle origin, e.g., skeletal muscle, where it is localized to the Z-disk. It is also present in BHK cells (9, 10) . (d) Glial fibrillary acidic protein (GFAP), the protein component of intermediate filaments of astrocytes, with a molecular weight of approximately 51 kdaltons (11) (12) (13) (14) . This molecule is apparently specific to cells of the central nervous system, although its presence in the peripheral nervous system has been reported (15) . (e) Neurofilaments, intermediate filaments of neurons of the central and peripheral nervous system, composed of three proteins with molecular weights 210 kdaltons, 160 kdaltons, and 70 kdaltons (16) . The relationship of these proteins to one another is not clear.
Polyclonal antisera made against a purified intermediate filament protein have been extremely useful in distinguishing among the different molecules. However, monoclonal antibodies afford a much higher degree of specificity than can be obtained with polyclonal sera because they recognize a single unique three-dimensional structure or sequence (epitope). Because the different intermediate filament proteins apparently contain similar as well as unique sequences (17, 18) , it should be possible to isolate hybridoma antibodies specific for a single intermediate filament protein, and others able to recognize more than one type of intermediate fdament protein (19) . A panel of hybridoma antibodies made against each of the filament proteins would therefore be useful in identifying unique and common sequences in these molecules. In addition, the antibodies specific for a single molecule could be used to identify the cellular origin of different neoplasms (7, 20, 21) and therefore would be clinically useful in the practice of pathology.
We report here the characterization of monoclonal antibodies generated against vimentin (decamin), cytokeratin from a human hepatoma cell line, and keratin from human stratum corneum. These antibodies exhibit unique reactivities with the different classes of intermediate filament proteins.
MATERIALS AND METHODS

Cells and Media
The following human cell strains and cell lines were obtained from Dr. Helene Smith, Peralta Institute, Oakland, CA: Hs-0074 Int, normal intestine; Hs-0767 BI, normal bladder; Hs-0700T, metastatic adenocarcinoma; Hs-0766T, metastatic pancreatic carcinoma; Hs-0746T, metastatic gastric carcinoma; Hs-0696T, metastatic adenocarcinoma; Hs-0578T, carcinosarcoma of breast. Human hepatocellular carcinoma cell lines Hep3B and HepG2 were obtained from Drs. David Aden and Barbara Knowles, Wistar Institute, Philadelphia, PA. Human fibreblasts were explanted from foreskins. Rhabdo-I was derived from a human rhabdomyosarcoma.
All cells, with the exception of Hs-0074 Int, were grown in DME supplemented with penicillin (100 U/ml) and streptomycin (100 /~g/ml). Hs-0074 Int was maintained in Eagle's minimal essential medium (MEM) supplemented with similar antibiotics. Newborn calf serum (I 0% vol/vol, Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) was used for all cells except Hep3B, and HepG2, which received 5% newborn caff serum, 5% fetal calf serum. All of the lines from Dr. Smith also received 2 /~g/ml insulin (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, CA).
Preparation of Intermediate Filament Proteins
Cells were grown to semi-confluence in 100-mm dishes and extracted with Triton-high salt according to Franke et aL (22) . Cell monolayers were washed two times with TNM buffer (10 mM Tris, 140 mM NaC1, 5 mM MgCI2, pH 7.6) and incubated with 1% Triton X-100 in TNM buffer for 1 rain at room temperature. The monolayers were washed twice with TNM buffer and exposed to 0.5% Triton X-100, 1.5 MKC1 for 30 rain at room temperature, after which the ceils were washed twice in TNM and scraped off the dish with a rubber policeman. The insoluble material was suspended in TNM and centrifuged at 10,000 rpm for 20 min at 4°C in a Sorvall centrifuge (Dupont InstrumentsSorvaU Biomedical Div., Dupont Co., Newtown, CT). The pellet was resuspended in 1% SDS, 50 mM Tris, pH 6.8, and stored at -20°C. The human fibroblast cytoskeletons remained attached to the dish during Triton-high salt extraction. All other cells extracted in this manner detached from the dish during the Tritonhigh salt incubation. When this occurred, the cell cytoskeletons were centrifuged at 10,000 rpm for 20 min at 4°C and washed with TNM by successive cantrifugations.
Keratin was extracted from human stratum corneum from the sole of the foot by the method of Sun and Green (23) . Fragments of stratum corneum were extracted overnight at 37°C in 5% SDS, 1% fl-mercaptoethanol at a concentration of 4 mg/mL The extracted tissue was centrifuged to remove the insoluble material and stored at -20°C.
Production of Hybridomas
Hybridoma antibodies to intermediate filament proteins were generated according to the basic outline of Krhler and Milstein (24) as modified by Nowinski et al. (25) . Preparations of intermediate filaments as described above from ~ l07 cells were solubilized in 1% SDS and injected intraperitoneally into a 5-wk-old BALB/c mouse; injections were repeated at 2 and 4 wk. 10 100-mm plates of semiconfluent cells were extracted for each injection. For the production of antikeratin antibodies, -200/tg of solubilized keratin was used for each immunization. 3 d following the third injection, the mouse was sacrificed by overanesthesia with ether. Spleen cells were fractionated into a single cell suspension by vigorous mincing and passage through fine wire mesh and fused to mouse myeloma cells (NS-1) at a ratio of 4:1 (spleen cells:myeloma cells) with polyethylene glycol (PEG). Hybrid clones were grown in RPMI-1640 (Gibco Laboratories) medium supplemented with 15% fetal calf serum, L-glutamine (1 mM), sodium pyruvate (1 mM), penicillin (100 U/ml), streptomycin (100/tg/ml; Gibco Laboratories), and 0.1 mM hypoxanthine, 0.40 #M aminopterin, 0.16 mM thymidine (HAT; Sigma Chemical Co., St. Louis, Me). Cultures were maintained at 7% CO2 concentration at 37°C. Cells were fed with RPMI/HAT at days 4 and 8; RPMI/HT at day 12; and RPMI-1640 every 4 d subsequent.
Clones were generally visible 5-10 d after the fusion, and supernatants tested when the wells were between one-third and one-half confluent, generally 2-3 wk following the fusion.
Screening of Hybridoma Antibodies
Clones producing antibodies to cytoskeletal preparations were identified by assaying hybridoma supernatant fluids for binding to formalin-, acetone-, or ethanol-fixed monolayers of cells by autoradiography or immune fluorescence techniques. For autoradiography, human fibroblasts or Hep3B cells were grown to confluence in 96-well microtiter plates, washed two times with 1% bovine serum albumin (BSA; Sigma Chemical Co.) in PBS, and fixed for 10 min at 4°C with 3.7% formaldehyde in PBS. The fixed ceils were washed four times in 1% BSA ill PBS. 50/d of supernatant were withdrawn from each hybridoma-containing well with a multichannel variable pipette (Finnipette, Labsyskms Oy, Helsinki, Finland) and added to the formalin-fixed ceils. Plates were incubated for 45 min at 37°C and washed three times with 1% BSA in PBS. 50/xl of immunoglobulin fraction of rabbit antisera to mouse IgG (Miles Laboratories, Elkhart, IN) diluted 1:400 in PBS were then added to all wells. Following incubation at 37°C for 45 rain and three serial washes with 1% BSA in PBS, 50/d of staphylococcal protein A (Sigma Chemical Co.), labeled via the lactoperoxidase method to a specific activity of 5.51 #Ci/~tg, was added to each well at a dilution of 105 cpm/50 ~tl. Following a 45-min incubation at 37°C and three serial washes with 1% BSA in PBS, positive wells were identified either by direct visualization following overnight autoradiography of the plates on Kodak XR-5 x-ray fill backed by a Dupont Lightning Plus intensifying screen at -70°C, or by punching out individual well bottoms with a hammer and 6-ram diameter steel rod and counting directly in a gamma counter. In the latter method, positive wells were defined as those displaying counts three standard deviations or greater beyond the mean background (wells incubated initially with NS-I supernatant or PBS). Positive wells identified by this initial screening were then tested by immunofluoresence to identify antibodies to intermediate filaments (see below).
Antikeratin antibodies were assayed by binding to keratin-coated dishes. Solubilized keratin (500 ng per well) was dried overnight on microtiter plates and the wells were washed with 1% BSA in PBS. 50 ,at of hybridoma supernatant was added to each well and processed as described above.
Wells that were positive in the initial screening assay and by immunofluorescence were cloned in a two-step procedure described elsewhere (25) . In the first "miniclone" step, 3-5 cells/well were seeded into one or two 96-well plates with a feeder layer of 106 thymocytes/well from 10-d-old BALB/c mice. The best growing cells, which also produced strongly reactive supernatants, were then
GOWN AND VOGEt
Unique and Cross-reacting Antibodies formally cloned by seeding one cell per three wells in three 96-well plates. Cloned cells were transferred 1o flasks, allowed to grow to high density, and l07 cells were injected intraperitoneally into pristane-primed BALB/c mice. 10 d to 2 wk later, ascites fluid (5-10 ml/mouse) was withdrawn. Cell lines producing positive supematants were frozen and stored at -70°C in 10% DMSO.
Im m unofluorescence
Ceils were plated in growth medium on Teflon-coated slides containing 12 wells (Meloy Laboratories, Springfield, VA) and allowed to attach overnight. The slides were washed in PBS, fixed in 95% ethanol or acetone (-20°C for 10 min) and air dried. 25 pl of diluted superaatant from bybridoma culture medium or ascites fluid were added to each well and the slides incubated at 37°C for 45 min in a humidified chamber. The slides were then washed in PBS and incubated with 25 #1 of FITC-conjugated goat anti-mouse IgG and IgM (1:40 dilution, Tago Inc., Burlmgame, CA) for 45 min at 37°C. The slides were washed with PBS, then water, and covershps were mounted with Aqua-Mount (Lemer Laboratories, New Haven, CT). Fluorescence was observed with a Zeiss fluorescence microscope with appropriate fluorescein excitation and emission filters. Fixation with cold 95% ethanol (-20°C) resulted in the best immunofluorescence pattern for the antivlmentin antibodies, whereas acetone fixation was better for the antihepatoma and antikeratin antibodies.
SDS Polyacrylamide Gel Electrophoresis
Slab gel electrophoresis was done according to Laemmli (26) . 8% gels were used to analyze whole cell lysates or Triton-high salt-insoluble material. Whole cell lysates were prepared by washing confluent 100-ram plates with TNM buffer and solubilizing the ceils with 1 ml of SDS sample buffer. Protein concentration of whole cell lysates was -0.4 mg/ml. Triton-high salt-insoluble material was dissolved in SDS sample buffer at a concentration of ~0.5 mg/ml. Samples were run with dithiothreitol (7.7 mg/ml). The absence of dithiothreitol in the SDS sample buffer did not affect the migration of the intermediate filament proteins in an 8% gel.
Electropho-retic Transfer of Proteins from Polyacrylamide Gels to Nitrocellulose Paper
To identify the antigen recognized by the hybridoma antibodies, proteins separated on 8% SDS polyacrylamide gels were electrophoresed onto nitroceLlulose paper and incubated with test antibodies. The procedure was done according to Burnette (27) using a transfer apparatus similar to that described by Towbin et al. (28) . Material tested included SDS lysates of whole ceils or the intermediate filament preparations made by Triton-high salt extraction of various cell lines. Pyronine Y (0.05%) was included in the SDS sample buffer to mark the bottom of the gel on the nitrocellulose paper. The SDS polyacrylamide gel was apposed to a sheet of nitrocellulose paper, and transfer was done overnight in 25 mM potassium phosphate, pH 6.5, at 100 mamp. The voltage gradient was -6 V/cm. Transferred proteins were identified on nitrocellulose by staining with amido black (0.1% in45% methanol/10% acetic acid) for 3 rain and destaining with 90% methanol/2% acetic acid.
Immunologic Detection of Proteins on Nitrocellulose Paper
All procedures were performed at room temperature. Nitrocellulose paper containing the transferred proteins was incubated in 25 ml of 5% bovine serum albumin (BSA) in 10 mM Tris, 0.9% saline, pH 7.4 (TSB buffer), for 90 min with gentle rocking. The antibody-containing aseites fluid was added directly to the BSA solution and incubated for another 90 min. The antibody was removed and the nitroceUulose washed according to the following regimen: (a) 50 ml of TSB, 10 min; (b) 50 mt of 0.05% Triton X-100 in TSB, 20 min; (c) 50 ml of @05% Triton X-100 in TSB, 20 min; and (d) 50 ml of TSB, 10 min. The nitrocellulose paper was then incubated with 5% BSA containing 5 x 105 cpm of 1251-goat antimouse IgG, (IgG and lgM specific [Tago Inc.]). After 60 min, the nitrocellulose paper was washed as above, dried, and exposed to Kodak XR-5 film with Dupont Lightning Plus enhancing filters. Exposure times varied from 6 to 18 h. Aseites fluid dilutions of 1:200-1:1,000 were routinely used, but ascites fluids were active to a dilution of 1:10,000.
GFAP and Neurofilament Protein Preparations
GFAP and neurofilament proteins prepared from rat spinal cord were obtained from Dr. F. C. Chin, Department of Neurology, Albert Einstein College of Medicine (29) . Anti-GFAP sera was a gift from Dr. James Goldman, Department of Neurology, Albert Einstein College of Medicine.
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Two-Dimensional Peptide Analysis
Peptide maps were prepared exactly as described by Sage et al. (30) . Individual protein bands were cut from gels, iodinated with Bolion-Hunter reagent (250 ~tCi per incubation, New England Nuclear, Boston, MA), and digested with proteinase K (40 /~g/ml, E.M. Biochemicals, Darmstadt, Germany) for 18 h at 37°C. Iodinated peptides (2 x 105 cpm) were spotted onto cellulose acetate plates (10 x 10 cm) and separated by electrophoresis in one dimension and chromatography in the second dimension. The dried plates were exposed to Kodak (BB-5) film with Dupont Lightning Plus enhancing filters for 2~5 h.
Immunocytochemistry
Autopsy-derived samples of human pancreas and skin were obtained from the University Hospital of the University of Washington. They were fLxed in Carnoy's fixative (60% ethanol, 30% chloroform, 10% acetic acid) for 3 h and embedded in paraffin. 7-/an sections were deparaffmized and endogenous peroxidase activity was blocked with 0.01% H202 in methanol (30 min). Monoclonal antibodies were applied to slides in dilutions ranging from 1:1000 to 1:8000 (30 min). Following a PBS wash, they were then incubated with biotinylated-anti-mouse IgG (Vector Laboratories, Burlmgame, CA) at a dilution of 1:500 (30 min). Again, following a PBS wash, a solution of avidin-biotinylated horseradish peroxidase complex (Vector Laboratories, Burlmgame, CA) was then applied (30 min), followed by an additional PBS wash. Peroxidase activity was identified by incubating with a solution of 0.1% 3,Y-diaminobenzidine (DAB) and @03% hydrogen peroxide in 0.05 M Tris buffer, pH 7.6. Sections were counterstained with methyl green. Table I lists the different antibodies to be discussed and the immunogens against which they are directed. 
RESULTS
Sources of Antigen from Different Tissues
Immunofluorescence Studies on Cell Unes and Immunological Identification of Antigens
Four monoclonal antibodies were isolated and characterized (Table I) . Immunofluorescence assays were performed on a Fig. 2 and summarized in Table II . The technique of "western blotting" was used to identify the antigen(s) recognized by each of these antibodies (27) . In these experiments, SDS lysates of whole cells were used (Fig. 3, lanes  a-J) , but identical results were obtained using the insoluble residue from Triton-high salt-extracted ceils (data not shown). The reactivity of the antibodies with purified neurofflaments (Fig. 3, lanes g and h) , GFAP (Fig. 3, lane g ) and keratin from stratum corneum (Fig. 3, lane i) was also examined.
17fiG3: Antibody 17BG3, generated against fibroblast cytoskeleton, reacts with human fibroblasts but not with Hep3B ( Fig. 2a and 2b) . In immunoblot experiments, the antibody recognizes vimentin (58 kdaltons) in fibroblasts and Hs-0578T, a breast carcinosarcoma (Fig. 3 A, lanes a and b) . All of the cells in Table II that react with 17fiG3 contain vimentin (58 kdaltons), even those of epithelial origin (bladder, fetal intestine, and two adenocarcinomas). These results are in agreement with Franke et al. (2) , who found that many epithelial cells that normally lack vimentin in vivo contain this protein when cultured in vitro.
Four cell lines, Hep3B, HepG2, A431, and Hs-0700T, fail to react with 17fiG3 by fluorescence assays (Table II) and do not contain any immunologically detectable vimentin (Fig. 3A,  lanes c-f) . Hep3B contains a minor band at 58 kdaltons (Fig.  1, lane b) but this molecule is not recognized by 17fiG3. Twodimensional peptide analyses demonstrate that vimentin from human fibroblasts and the 58-kdalton protein from Hep3B are markedly different (see below).
In some assays, varying reactivity with a protein at 44 kdaltons is seen in cells that either possess or lack vimentin. For example, a 44-kdalton band is recognized by 17fig3 in A431 (Fig. 3 A, lane e) . This reactivity varies from cell line to cell line and from assay to assay. We do not as yet understand this variable reactivity.
The antivimentin antibody cross reacts with GFAP and the high molecular weight bands of keratin (66 kdaltons, 57 kdaltons) (Fig. 3 A) , but does not recognize the neurofdament peptides. The recognition of GFAP, although weak on this autoradiogram, is stronger in others (data not shown). In addition, we cannot dilute the antibody so that it retains reactivity with vimentin, but no longer recognizes GFAP or keratin. When approximately equal amounts of vimentin, keratin, and GFAP are loaded on a gel, recognition of each of these proteins at different antibody dilutions is identical (data not shown).
It is possible that the 52-kdalton band in the neurofilament preparation is not GFAP but, instead, a proteolytic breakdown product of vimentin (31) . This possibility is unlikely because polyclonal anti-GFAP sera (supplied by Dr. James Goldman, Albert Einstein College of Medicine) reacts with the 52-kdalton band but does not recognize vimentin (data not shown).
35fill l l: Hybridoma 35drill, made against Hep3B intermediate fdaments, decorates filaments of Hep3B but not of flbroblasts ( Fig. 2 c and 2 d) . The antibody recognizes a 54-kdalton peptide in Hep3B, HepG2, A431, and Hs-0700T, all epithelial cell neoplasms (Fig. 3 B) . Hs-0696T and Hs-0746T, both of which are positive by fluorescence, also contain the 54-kdalton protein (data not shown). No peptides are identified in fibroblasts or Hs-0578T, nor in the epithelial ceils (bladder, fetal intestine) listed in Table II that Adenocarcinoma, metastatic to muscle + + + -Ascites fluids were tested by immunofluorescence at dilutions of 1:100. The filaments against which the antibodies were generated.
TABL~ II
Immunofluorescence with Monoclonal Antibodies
no other intermediate filament proteins (Fig. 3 B) . It is therefore highly specific, recognizing only a 54-kdalton protein present in many cells of epithelial origin. cells tested (Table II) . In immunoblot experiments, it reacts with several types of intermediate filament proteins (Fig. 3 c) . It binds to vimentin (58 kdaltons) in fibroblasts (lane a), the 54-kdalton and 56-kdalton proteins of A431 (lane e), GFAP (lane g), and all the major keratin bands (lane i). It does not, however, recognize the different neurofilament proteins (lanes g and h). The antibody also recognizes a 44-kdalton and 40-kdalton molecule in HepG2, and 44-kdalton proteins in A431 and Hs-0700T. The reactivity with these lower molecular weight bands is highly variable, similar to the variable reactivity of 17fiG3 with the 44-kdalton protein of A431. This antibody therefore appears to recognize a common epitope in many different intermediate filament proteins.
The antibody does not recognize the 54-kdalton proteins of the hepatoma lines or Hs-0700T even though these lines are positive in immunofluorescence assays. One explanation for this observation is that the antibody cannot recognize the epitope in the SDS denatured protein from these cells, but can GOWN AND VOGEL Unique and Cross-reacting Antibodies recognize the SDS denatured protein from A431. This implies that the 54-kdalton proteins of these different cells are not identical; two-dimensional peptide maps show that these peptides are indeed different (see below).
34fl~t2: Hybridoma 34flE12, generated against keratin from stratum corneum, is only positive by immunofluorescence on A431, the epidermoid carcinoma (Fig. 2 g ). It is negative on fibroblasts, Hep3B, and all other cells (Table II) . This antibody binds to the 66-kdalton and 57-kdalton proteins in stratum corneum and reacts less strongly with the 51-kdalton and 49-kdalton molecules (Fig. 3 D, lane i) . Interestingly, the antibody identifies proteins of 66 kdaltous and 57 kdaltons in all cells tested, even those negative in immunofluorescence assays. These peptides are very minor components of the Triton-high salt-insoluble material from cells. Thus, although specific in immunofluorescence assays on tissue culture cells and immunoperoxidase tests on intact tissue (see below), the antibody recognizes similar molecular weight peptides in all cells in immunoblot experiments.
The immunoautoradiograph of the antikeratin antibody always has this "smeared" appearance, which may be related to the degree of reduction of the proteins. If the gels are run without reducing agent, the antibody does not recognize any bands on the nitrocellulose paper either in the position of the keratin bands or elsewhere (data not shown). The keratin preparation used as immunogen was reduced with fl-mercaptoethanol, so we believe the antibody may recognize only the reduced protein. 
Two-Dimensional Peptide Maps
The immunofluorescence and "western blot" results raise questions about similarities and differences among the different intermediate filament proteins. We performed two-dimensional peptide analyses to answer the following three questions: (a) are vimentin and the 58-kdalton protein in Hep3B related? (b) Are the 54-kdalton peptides of Hep3B and A431 identical? and (c) Does the 66-kdalton protein from stratum corneum resemble the 66-kdalton molecules from Hep3B and A431? VIMENTIN VS. THE 58-KDALTON PROTEIN FROM rIEP3a: The peptide maps of vimentin and the 58-kdalton protein from Hep3B are quite different (Fig. 4 a and 4 b) . Additionally, the maps of the 54-kdalton proteins from Hep3B (Fig. 4 c) and A431 (Fig. 4 d) differ from that of vimentin, as does the map of the 44-kdalton band from A431 (Fig. 4 e) . Thus, vimentin and these other proteins are clearly different. "Western blot" experiments demonstrate that antibody 35flD12 recognizes the 54-kdalton protein from A431 but not Hep3B. The peptide maps show both similarities and differences in the peptides (Fig. 4 c and d) . The more hydrophobic, less-charged spots are almost identical, but the more-charged peptides show many differences. We conclude that the variation in reactivity with 35flD12 results from structural or sequence differences in the two molecules. Antibody 34flE12 recognizes a 66-kdalton band in preparations of stratum corneum and a protein of similar molecular weight in all cells tested. The 66-kdalton protein from stratum corneum (Fig. 4 420 TuE JOURNAL 0[ CELL BIOLOGY . VOLUME 95, 1982
J0 differs from the 66-kdalton molecules of Hep3B (Fig. 4 g ) and A 431 (Fig. 4 h) , whereas these latter two proteins are practically identical. The cell-derived 66-kdalton proteins probably share a common epitope(s) with the molecule from stratum corneum.
The reason for the difference in immunofluorescence stainhag by 34flE12 on A431 and Hep3B remains unclear. The peptide maps of the 66-kdalton molecules from these two cells are identical, yet antibody 34flE12 decorates the intermediate filaments of only A431. Possible explanations include very subtle sequence differences in the molecules, different intercellular localizations of the proteins in the two cells, or a difference in the way the molecules associate with the intermediate filaments. For example, in Hep3B the 66-kdalton protein may be surrounded by other proteins such that the antibody does not have access to the epitope.
Reactivity with Intact Tissues
To further characterize these antibodies, we examined their ability to react with tissue obtained from autopsy and surgical specimens. Samples of skin and pancreas were fixed in Carnoy's solution, and reactivity was demonstrated by immunoperoxidase techniques. A more detailed analysis of reactivity is in preparation.
35fl H l 1" The antihepatoma intermediate filament antibody reacts with pancreatic acinar and duct cells (Fig. 5 c) and sweat gland epithelia (data not shown). It fails to recognize epidermis and mesenchymal tissue such as blood vessels and dermis (Fig.  5 a) . The absence of decoration of squamous epithelia is consistent with the inability of this antibody to recognize keratin from stratum corneum and suggests that the 54-kdalton protein recognized by this antibody is specific for nonsquamous epithelium. In addition, the antibody does not react with skeletal muscle or nervous tissue (data not shown).
34fie 12: The antikeratin antibody is specific for epidermis and some but not all nonsquamous epithelium. The full thickness of the epidermis is heavily stained with this antibody (Fig.  5 b) , as is the epithelium of the sweat glands (data not shown). In the pancreas, the duct ceils are positive, but the acinar cells are negative (Fig. 5 d) . Mesenchymal tissues such as blood vessel, smooth muscle, skeletal muscle, and dermis, as well as nervous tissue, fail to react with this antibody (data not shown). Thus this antibody reacts with squamous epithelium and a subset of nonsquamous epithelium.
17fiG3: This antibody most strongly reacts with the media of blood vessels (Fig. 5 e) and also manifests a weaker reactivity with dermal fibrous tissue (data not shown). The antibody reacts with none of the epithelial cells in these sections, including epidermis, sweat gland, pancreatic acinar cells, or pancreatic duct cells (data not shown). Thus, this antibody is specific for mesenchymal tissue. reacts with the high molecular weight keratins in stratum corneum. Thus these antibodies are highly specific. The antivimentin antibody 17fiG3 crossreacts with GFAP and the high molecular weight keratins from stratum corneum. Hybridoma 35flD12 is relatively nonspecific in that it binds to vimentin, GFAP, the 54-kdalton protein of epithelial cells, and all the 422 THE JOURNAL OF CELL BIOLOGY -VOLUME 95, 1982
proteins from stratum corneum. The different patterns of crossreactivity suggest that vimentin, the 54-kdalton protein of Hep3B and A431, GFAP, and multiple proteins in the keratin family share common epitopes. Hybridoma 35flD12 best illustrates this point because it recognizes all of these molecules. The only filament proteins that do not react with these antibodies are the neurofilament peptides. The lack of reactivity with the neurofilament peptides is not due to the inability of the high molecular weight proteins to transfer onto nitrocellulose paper, because the 200-kdalton and 160-kdalton proteins are visible on amido black-stained strips of nitrocellulose, and monoclonal antibodies made to the 200-kdalton protein recognize this protein on "western blots" (data not shown). It is likely that the neurofilament proteins also share antigenic determinants with other intermediate filament proteins because a monoclonal antibody generated against GFAP from spinal cord recognizes all the other intermediate filament peptides (19) . One could argue that the intermediate filament proteins of various molecular weights identified by these antibodies are not truly different, but instead represent different proteolytic fragments of the same molecule (31) . This explanation is ruled out by the two-dimensional peptide maps that clearly demonstrate that many of these molecules are unique proteins. The vimentin map is distinct from that of the 58-kdalton protein from Hep3B, the 54-kdalton epithelial proteins, and the 66-kdalton keratin peptide. This latter molecule and the 54-kdalton epithelial proteins also differ. In addition, the 52-kdalton protein in the neurofdament preparation and fibroblast vimentin probably differ because a polyclonal anti-GFAP sera recognizes this protein and not vimentin (data not shown).
Antikeratin Antibody 34fl E12
Hybridoma 34flE12, which recognizes proteins of 66 kdaltons and 57 kdaltons in stratum corneum, yields unexpected results. In immunofluorescence assays performed on a variety of tissue culture cell lines, the antibody decorates only the intermediate filaments of epidermoid carcinoma cells. When assayed on Carnoy's luted tissue from autopsy and surgical specimens, the antibody decorates squamous epithelium and some, but not all, nonsquamous epithelium ( Fig. 5 b and d) . For example, pancreatic duct epithelium reacts with 34flE12, but pancreatic acinar cells do not. Similarly, the antibody recognizes bile ducts in liver but not hepatocytes (data not shown). In immunoblot experiments, the antibody recognizes proteins of 66 kdaltons and 57 kdaltons in all cells tested, including cultured cells negative in immunofluorescence assays and intact tissue negative in immunoperoxidase assays. A protein of 66 kdaltons is identified in immunoblots of spleen and lymph node, neither of which reacts with the antibody in immunoperoxidase assays (data not shown). Therefore, the antibody recognizes peptides of similar molecular weight in all ceils examined by "western blots" yet reacts only with specific tissues in immunofluorescence or immunoperoxidase assays.
We do not understand the reason for this apparent discrepancy in reactivity. One could argue that the 66-kdalton proteins of positive and negative cells differ such that the antibody recognizes the native protein of only A431 cells, but recognizes the SDS denatured proteins of all ceils. This explanation is unlikely because the peptide maps of the 66-kdalton proteins from A431 and Hep3B are identical (Fig. 4) . However, there still may be subtle sequence differences between the two molecules that are not demonstrated by two-dimensional maps. Another explanation is that the 66-kdalton and 57-kdalton proteins are organized in filaments in only A431. These antigens may have a different intracellular location in the negative cells or may be localized in filaments such that the epitope is masked or blocked, thereby preventing antibody binding. A third possibility is that the positive cells may contain more of these proteins than the negative cells. However, we have not consistently seen quantitative differences between positive and negative cells. Finally, it is possible that the "blot" procedure does not identify the correct antigen, but instead shows a serendipitous reactivity with molecules unrelated to intermediate filaments in the cell lysates. Such a phenomenon was observed with monoclonal antibodies to the Thy-l antigen that also cross-react with vimentin (32). This explanation seems unlikely for the following reasons: (a) Pruss et al. 09) have described a monoclonal antibody capable of recognizing all classes of intermediate filaments that also identifies a 66-kdalton protein in many cells, and (b) A 66-kdalton peptide is present in cytoskeletal preparations from all cells, including those that do not react with 34flE12 (Fig. 1) .
The peptide map data also show that the 66-kdalton protein from stratum corneum is not identical to the 66-kdalton proteins of A431 or Hep3B (Fig. 4) . Therefore these three molecules must contain a common epitope(s) recognized by antibody 34flE12.
The S4-kdalton Protein of Epithelial Cells In Vitro: Differentiation of "'Cytokeratins'" and Keratins from Stratum Corneum
Nonsquamous epithelial cells generally react with antibodies made against keratin from bovine hoof or human skin (5) (6) (7) (8) . The proteins that comprise the intermediate filaments of epithelial cells have therefore been termed "cytokeratins". Hybridoma 35fill11 demonstrates that a "cytokeratin" from hepatoma cells possesses a unique epitope not found in the family of keratins from stratum corneum. Similar observations have been made by Franke et al. (5) , using polyclonal sera raised against bovine hoof keratin, and sera directed against individual intermediate filament proteins from mouse liver. Additionally, Lane (33) has made monoclonal antibodies to cytokeratin that recognize 45-kdalton proteins in PtK1 cells and also stain nonsquamous epithelium.
35fill I 1 identifies a 54-kdalton protein in many tissue culture epithelial cell lines and decorates almost all nonsquamous epithelium in Carnoy's-fixed tissue (manuscript in preparation) but does not recognize proteins from stratum corneum and does not react with squamous epithelium (Fig. 5 a) . Therefore, it appears that the 54-kdalton protein is a major component of the intermediate filaments of nonsquamous epithelium, and antibody 35flHll can be used to distinguish squamous from nonsquamous epithelium. However, we cannot be certain of this latter statement because A431, a tissue culture line derived from a squamous carcinoma, contains a 54-kdalton protein recognized by 35fill11. It remains to be determined whether the presence of the 54-kdalton protein in A431 is the result of tissue culture, or whether the 54-kdalton protein is present in squamous carcinomas and not in normal squamous epithelium.
Peptides of Similar Molecular Weights in Different Cells
Some cells contain intermediate filament proteins of similar molecular weight that can be distinguished on the basis of reactivity with the different monoclonal antibodies. For example, a 54-kdalton peptide is present in both Hep3B and A43 I, but in immunoblot experiments antibody 35flD 12 reacts with only the molecule from A431 cells. This result suggests that the epitope may be modified or that the arrangement or distribution of the epitope in these two molecules is different. Similarly, antibody 17fiG3 does not bind to the 58-kdalton protein in Hep3B, suggesting that this protein and vimentin from human fibroblasts are not identical. The peptide maps demonstrate that these molecules do differ. The 54-kdalton proteins of A431 and Hep3B are not identical, and vimentin and the 58-kdalton protein of Hep3B are markedly different. These results show that much sequence heterogeneity may exist within a specific class of intermediate filament protein, even among those of similar molecular weight.
Clinical Application of these Antibodies
One objective of this project was to generate antibodies specific for different cell types. For tissue culture cells, this seems to have been accomplished. Antibody 17fiG3 recognizes vimentin, a mesenchymal cell marker (20, 21) . Reaction of 17fiG3 with cultured epithelial ceils results from the presence of vimentin in these cells (data not shown) (2) . Although capable of reacting with keratin in immunoblot experiments, the antibody does not recognize epidermoid carcinoma cells (A431) and does not decorate epithelial ceils that normally do GOWN AND VOG[£ Unique and Cross-reacting Antibodies not contain vimentin (Fig. 5). The antihepatoma filament  antibody 35flHl 1 recognizes a 54-kdalton (Fig. 5) . The ant[keratin antibody 34BE 12 recognizes squamous epithelium and some, but not all, nonsquamous epithelium. Antibodies 35BH 11 and 34/~E 12 identify two unique cytokeratin epitopes expressed in different epithelial cells and therefore may be useful in distinguishing different carcinomas (neoplasms of epithelial origin). We are beginning to use these antibodies clinically to determine the ceUular origin of poorly differentiated neoplasms.
